- Home
- /
- Treatment
- /
- Page 131
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Uridine 5′-triphosphate | Primary ciliary dyskinesia | Inspire Pharmaceuticals, Inc.;4222 Emperor Boulevard, Suite 470;Durham, North Carolina, 27703 | June 26, 1996 | |
Methylnaltrexone | Chronic opioid-induced constipation unresponsive to conventional therapy | Progenics Pharmaceuticals, Inc.;765 Old Saw Mill River Rd.;Tarrytown, New York, 10591 | June 17, 1996 | |
Selective inhibitor of polymorphonuclear leukocyte (PMN) elastase | Therapeutic management of patients with lung disease attributable to cystic fibrosis | DuPont Pharmaceuticals Company;Chestnut Run, Maple Run, Centre Rd.;Wilmington, Delaware, 19805 | June 4, 1996 | |
Collagenase clostridium histolyticum | Advanced (involutional or residual stage) Dupuytren's disease | Auxilium Pharmaceuticals, Inc.;40 Valley Stream Parkway;Malvern, Pennsylvania, 19335 | May 23, 1996 | |
Arcitumomab | Diagnosis and localization of primary, residual, recurrent and metastatic medullary thyroid carcinoma | Immunomedics, Inc.;300 American Road;Morris Plains, New Jersey, 07950 | May 10, 1996 | |
Etiocholanedione | Prader-Willi syndrome | SuperGen, Inc.;4140 Dublin Blvd., Suite 200;Dublin, California, 94568 | May 7, 1996 | |
Amphotericin B lipid complex | Invasive coccidioidomycosis | The Liposome Company, Inc.;One Research Way;Princeton, New Jersey, 08540 | May 6, 1996 | |
Amphotericin B lipid complex | Invasive zygomycosis | The Liposome Company, Inc.;One Research Way;Princeton, New Jersey, 08540 | May 6, 1996 | |
Liposomal prostaglandin E1 injection | Acute respiratory distress syndrome | Liposome Company, Inc.;One Research Way;Princeton, New Jersey, 08540 | April 25, 1996 | |
Idoxuridine | Nonparenchymatous sarcomas | NeoPharm, Inc.;225 East Deerpath, Suite 250;Lake Forest, Illinois, 60045 | April 8, 1996 | |
Lipid/DNA human cystic fibrosis gene | Cystic fibrosis | Genzyme Corporation;Metrowest Place, 15 Pleasant St. Connector;Framingham, Massachusetts, 01701 | April 8, 1996 | |
Somatropin (r-DNA) for injection | Children with AIDS-associated failure-to-thrive including AIDS-associated wasting | EMD Serono, Inc.;One Technology Place;Roackland, Massachusetts, 02370 | March 26, 1996 | |
Collagenase clostridium histolyticum | Peyronie's disease | Auxilium Pharmaceuticals, Inc.;640 Lee Road;Chesterbrook, Pennsylvania, 19087 | March 12, 1996 | |
Rifapentine | Prophylactic treatment of Mycobacterium avium complex in patients with AIDS and a CD4+ count less than or equal to 75/mm3 | Hoechst Marion Roussel, Inc.;P.O. Box 9627, Mail Station: H3-M2516;Kansas City, Missouri, 64134 | March 12, 1996 | |
N-[4-(trifluoromethyl)phenyl]-5-methylisoxazole-4-carboxamide | Ovarian cancer | Sugen, Inc.;230 East Grand Ave.;South San Francisco, California, 94080 | March 12, 1996 | |
Interferon beta-1a | Patients with secondary progressive multiple sclerosis | EMD Serono, Inc.;One Technology Place;Rockland, Massachusetts, 02370 | March 11, 1996 | |
Thalidomide | HIV-associated wasting syndrome | Celgene Corporation;7 Powder Horn Dr.;Warren | March 11, 1996 | |
Antihemophilic factor (recombinant) | Hemophilia A | Wyeth Pharmaceuticals, Inc.;P. O. Box 8299;Philadelphia, Pennsylvania, 19101 | February 8, 1996 | |
Testosterone | Weight loss in AIDS patients with HIV-associated wasting | Unimed Pharmaceuticals, Inc.;901 Sawyer Rd.;Marietta, Georgia, 30062 | February 5, 1996 | |
Dihydrotestosterone | Weight loss in AIDS patients with HIV-associated wasting | Besins Internaitonal, US Inc.;610 Herndon Parkway, Suite 750;Herndon, Virginia, 20170 | February 5, 1996 | |
Albendazole | Neurocysticercosis due to Taenia solium as: 1) chemotherapy of parenchymal, subarachnoidal and racemose (cysts in spinal fluid) neurocysticercosis in symptomatic cases and 2) prophylaxis of epilepsy and other sequelae in asymptomatic neurocysticercosis | Amedra Pharmaceuticals LLC;2 Walnut Grove Drive, Suite 190;Horsham, Pennsylvania, 19044 | January 18, 1996 | |
Albendazole | Alveolar echinococcosis | Amedra Pharmaceuticals LLC;2 Walnut Grove Drive, Suite 190;Horsham, Pennsylvania, 19044 | January 17, 1996 | |
Valine, isoleucine and leucine | Hyperphenylalaninemia | Leas Research Products;78 Fallon Drive;North Haven, Connecticut, 06473 | January 5, 1996 | |
Antihemophilic factor (human) | Von Willebrand disease | Grifols Biologicals Inc.;5555 Valley Boulevard;Los Angeles, California, 90032 | January 5, 1996 | |
Mecasermin | Growth hormone insensitivity syndrome | Ipsen Biopharmaceuticals, Inc.;106 Allen Road;Basking Ridge, New Jersey, 07920 | December 12, 1995 |